相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Body Composition, Adherence to Anthracycline and Taxane-Based Chemotherapy, and Survival After Nonmetastatic Breast Cancer
Elizabeth M. Cespedes Feliciano et al.
JAMA ONCOLOGY (2020)
Impact of Older Age on the Exposure of Paclitaxel: a Population Pharmacokinetic Study
Marie-Rose B. S. Crombag et al.
PHARMACEUTICAL RESEARCH (2019)
Clinical Pharmacokinetics of Paclitaxel Monotherapy: An Updated Literature Review
Tore B. Stage et al.
CLINICAL PHARMACOKINETICS (2018)
A comparative study of software programmes for cross-sectional skeletal muscle and adipose tissue measurements on abdominal computed tomography scans of rectal cancer patients
Jeroen L. A. van Vugt et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2017)
A review of body composition and pharmacokinetics in oncology
Jessica J. Hopkins et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2017)
Body Composition as a Predictor of Toxicity in Patients Receiving Anthracycline and Taxane-Based Chemotherapy for Early-Stage Breast Cancer
Shlomit Strulov Shachar et al.
CLINICAL CANCER RESEARCH (2017)
Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)aEuro
M. Joerger et al.
ANNALS OF ONCOLOGY (2016)
Improving the estimation of parameter uncertainty distributions in nonlinear mixed effects models using sampling importance resampling
Anne-Gaelle Dosne et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2016)
Pharmacokinetically based dosing of weekly paclitaxel to reduce drug-related neurotoxicity based on a single sample strategy
Stefanie Kraff et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
Induction chemotherapy followed by surgery for advanced oesophageal cancer
E. L. A. Toxopeus et al.
EJSO (2015)
Influence of Drug Formulation on OATP1B-Mediated Transport of Paclitaxel
Annemieke J. M. Nieuweboer et al.
CANCER RESEARCH (2014)
Conventional Dosing of Anticancer Agents: Precisely Wrong or Just Inaccurate?
S. Bins et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
A Pharmacogenetic Predictive Model for Paclitaxel Clearance Based on the DMET Platform
Anne-Joy M. de Graan et al.
CLINICAL CANCER RESEARCH (2013)
Body composition in chemotherapy: the promising role of CT scans
Carla M. M. Prado
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2013)
Influence of Smoking on the Pharmacokinetics and Toxicity Profiles of Taxane Therapy
Anne-Joy M. de Graan et al.
CLINICAL CANCER RESEARCH (2012)
Evaluation of a Pharmacology-Driven Dosing Algorithm of 3-Weekly Paclitaxel Using Therapeutic Drug Monitoring
Markus Joerger et al.
CLINICAL PHARMACOKINETICS (2012)
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
P. van Hagen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
An exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity
Carla M. M. Prado et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Evaluation of alternate size descriptors for dose calculation of anticancer drugs in the obese
Alex Sparreboom et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Flat-fixed dosing versus body surface area-based dosing of anticancer drugs in adults: Does it make a difference?
Ron H. J. Mathijssen et al.
ONCOLOGIST (2007)
Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image
W Shen et al.
JOURNAL OF APPLIED PHYSIOLOGY (2004)
Role of body surface area in dosing of investigational anticancer agents in adults, 1991-2001
SD Baker et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
分享论文
